Overview
Neeltje Allard practices practicing medicine in Nijmegen, Netherlands.
Their clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Bullae, Abdominal Obesity Metabolic Syndrome, and Leukemia.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Neeltje E. Allard
Is Neeltje E. Allard a top-rated expert for Chronic Myelogenous Leukemia (CML)?
MediFind is an objective health platform that identifies experts based on real-world data. Neeltje E. Allard is classified as an Experienced expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Neeltje E. Allard participate in research or clinical trials?
Yes. Neeltje E. Allard has published 14 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Neeltje E. Allard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Abdominal Obesity Metabolic Syndrome
- BullaeAllard isExperienced. Learn about Bullae.
- Chronic Myelogenous Leukemia (CML)
- LeukemiaAllard isExperienced. Learn about Leukemia.